mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
4e-06 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-05 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
0.0001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |